| Eric B. Williams, Md, Pllc | |
|
12801 N Central Expy Ste 350 Dallas TX 75243-1716 | |
| (214) 702-5336 | |
| (972) 773-9843 |
| Full Name | Eric B. Williams, Md, Pllc |
|---|---|
| Speciality | Psychiatry & Neurology |
| Location | 12801 N Central Expy Ste 350, Dallas, Texas |
| Authorized Official Name and Position | Eric B. Williams (OWNER) |
| Authorized Official Contact | 2147025336 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Eric B. Williams, Md, Pllc 12801 N Central Expy Ste 350 Dallas TX 75243-1716 Ph: (214) 702-5336 | Eric B. Williams, Md, Pllc 12801 N Central Expy Ste 350 Dallas TX 75243-1716 Ph: (214) 702-5336 |
| NPI Number | 1003251570 |
|---|---|
| Provider Enumeration Date | 05/09/2013 |
| Last Update Date | 02/17/2022 |
| Certification Date | 02/17/2022 |
| Medicare PECOS PAC ID | 8123332087 |
|---|---|
| Medicare Enrollment ID | O20150805008670 |
News Archive
Elorac, Inc., a rapidly growing specialty pharmaceutical company focused on the treatment of dermatological disorders, announced results of two Phase III studies of its patented Carbamide Peroxide (CPO) solution for the treatment of inflammatory acne vulgaris and rosacea at the Lazard Capital Markets 7th Annual Healthcare Conference in New York.
UK researchers have found that a newly discovered layer of the human eye is an important part of the structural tissue that helps to maintain intraocular pressure and thus may play a role in the development of glaucoma.
African American women with early stage, invasive breast cancer were 12 percent less likely than Caucasian women with the same diagnosis to receive a minimally invasive technique, axillary sentinel lymph node (SLN) biopsy, even as the procedure had become the standard of surgical practice, according to research from The University of Texas MD Anderson Cancer Center.
Evidence shows that early detection and treatment of cancer can significantly improve health outcomes, however women in Mississippi, particularly in underserved populations, experience the worst health outcomes for cervical, breast, and oropharyngeal cancer.
› Verified 3 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003251570 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | P0809 (Texas) | Primary |
| Provider Name | Eric B Williams |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1861622730 PECOS PAC ID: 1557585866 Enrollment ID: I20140606000440 |
News Archive
Elorac, Inc., a rapidly growing specialty pharmaceutical company focused on the treatment of dermatological disorders, announced results of two Phase III studies of its patented Carbamide Peroxide (CPO) solution for the treatment of inflammatory acne vulgaris and rosacea at the Lazard Capital Markets 7th Annual Healthcare Conference in New York.
UK researchers have found that a newly discovered layer of the human eye is an important part of the structural tissue that helps to maintain intraocular pressure and thus may play a role in the development of glaucoma.
African American women with early stage, invasive breast cancer were 12 percent less likely than Caucasian women with the same diagnosis to receive a minimally invasive technique, axillary sentinel lymph node (SLN) biopsy, even as the procedure had become the standard of surgical practice, according to research from The University of Texas MD Anderson Cancer Center.
Evidence shows that early detection and treatment of cancer can significantly improve health outcomes, however women in Mississippi, particularly in underserved populations, experience the worst health outcomes for cervical, breast, and oropharyngeal cancer.
› Verified 3 days ago
News Archive
Elorac, Inc., a rapidly growing specialty pharmaceutical company focused on the treatment of dermatological disorders, announced results of two Phase III studies of its patented Carbamide Peroxide (CPO) solution for the treatment of inflammatory acne vulgaris and rosacea at the Lazard Capital Markets 7th Annual Healthcare Conference in New York.
UK researchers have found that a newly discovered layer of the human eye is an important part of the structural tissue that helps to maintain intraocular pressure and thus may play a role in the development of glaucoma.
African American women with early stage, invasive breast cancer were 12 percent less likely than Caucasian women with the same diagnosis to receive a minimally invasive technique, axillary sentinel lymph node (SLN) biopsy, even as the procedure had become the standard of surgical practice, according to research from The University of Texas MD Anderson Cancer Center.
Evidence shows that early detection and treatment of cancer can significantly improve health outcomes, however women in Mississippi, particularly in underserved populations, experience the worst health outcomes for cervical, breast, and oropharyngeal cancer.
› Verified 3 days ago
Metrocare Services Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1380 River Bend Dr, Dallas, TX 75247 Phone: 214-743-6159 | |
Lifenet Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 9708 Skillman St, Dallas, TX 75243 Phone: 214-221-5433 Fax: 214-932-1977 | |
Bienstar Counseling Services Pllc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 13140 Coit Rd Ste 326, Dallas, TX 75240 Phone: 214-682-7842 | |
Howdy Pediatrics, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 539 W Commerce St Ste 608, Dallas, TX 75208 Phone: 214-494-0448 Fax: 210-547-2046 | |
Lucienne Cohen Therapy, Pllc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 4007 Bowser Ave Apt E, Dallas, TX 75219 Phone: 617-823-3007 | |
Developmental Pathways Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 325 N Saint Paul St Ste 3100, Dallas, TX 75201 Phone: 214-432-3777 Fax: 800-434-3012 |